CHARMACY PHAR (02289) · Company profile · Eqvero

CHARMACY PHAR

02289HKEX

Unit: CNY	FY2025	FY2024	FY2023	FY2022	FY2021
Revenue	4.33 bn CNY	4.39 bn CNY	4.35 bn CNY	4.14 bn CNY	3.76 bn CNY
Cost of revenue	4.02 bn CNY	4.08 bn CNY	4.09 bn CNY	3.88 bn CNY	3.53 bn CNY
Selling, general and administrative expense	181.37 m CNY	175.27 m CNY	170 m CNY	162.57 m CNY	151.85 m CNY
Operating profit after depreciation	131.54 m CNY	135.21 m CNY	108.28 m CNY	93.49 m CNY	73.9 m CNY
Operating profit before depreciation	162.86 m CNY	167.38 m CNY	134.75 m CNY	124.16 m CNY	105.94 m CNY
EBIT	131.54 m CNY	135.21 m CNY	108.28 m CNY	93.49 m CNY	73.9 m CNY
EBITDA	162.86 m CNY	167.38 m CNY	134.75 m CNY	124.16 m CNY	105.94 m CNY
Interest expense	56.83 m CNY	62.46 m CNY	40.79 m CNY	35.07 m CNY	41.52 m CNY
Profit before tax	64.31 m CNY	71.19 m CNY	67.42 m CNY	122.05 m CNY	32.98 m CNY
Income tax expense	18.04 m CNY	17.91 m CNY	16.08 m CNY	31.67 m CNY	9.83 m CNY
Income before extraordinary items	46.27 m CNY	53.28 m CNY	51.35 m CNY	90.38 m CNY	23.15 m CNY
Common dividends	32.4 m CNY	—	—	48.6 m CNY	—
Total dividends	32.4 m CNY	—	—	48.6 m CNY	—

Quotes are end-of-day data. Content is for research purposes and is not investment advice.